Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DU-176b for prevention of venous thromboembolism after total hip arthroplasty
2004-004415-29Phase 2Completed
- Sponsor
- Daiichi Medical Research
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of edoxaban in venous thromboembolism (VTE), sponsored by Daiichi Medical Research. Primary endpoint: Incidence of confirmed venous thromboembolism. Started Feb 2005; status: completed.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2004-004415-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004415-29.